Q1 2026 Talphera Inc Earnings Call Transcript

May 13, 2026 / 08:30 PM GMT

Release Date Price: $0.9013 (+5.11%)

Transcript 10-Q8-K

Key Points

Positve

Talphera Inc (TLPH) achieved a 50% enrollment milestone in the NEFRO study and has exceeded this level, indicating strong progress.
The company is on track to complete enrollment in the NEFRO CRRT study this year and plans to file a PMA for potential approval in 2027.
Nine out of twelve activated sites align with the new target site profile, with nephrologists as leads, contributing to over 90% of patient enrollment.
The study sites and principal investigators are highly engaged and supportive of the new CRRT anticoagulant.
Talphera Inc (TLPH) has a cash balance of $21.1 million, which, combined with future financing tranches, is expected to support operations through potential NIAID PMA approval next year.

Negative

Cash operating expenses increased to $3.9 million in Q1 2026 from $2.9 million in Q1 2025, primarily due to higher NIAID development expenses.
The company is not planning additional enrollment updates until the study is completed, which may leave investors seeking more frequent updates.
Two new study sites are joining late and are not expected to significantly contribute to the study, potentially limiting their impact.
The study's completion and data announcement are dependent on the flow of qualifying patients, which could introduce timing uncertainties.
The company faces risks and uncertainties related to forward-looking statements, as highlighted in their SEC filings.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TLPH.OQ - Talphera Inc
Q1 2026 Talphera Inc Earnings Call
May 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Telfera First Quarter 2026 Financial Resource Conference Call.

This call is being webcast live via the events page of the investor section of Telfera's website at WWW dot Telfera.com.

You may listen to a replay of this webcast by going to the investor section of Telfera's website.

I would now like to turn the call over to Rafi Asadorian, Telfair's Chief Financial Officer. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, and thank you for joining us on the call today.

Today, we announced our first quarter 2026

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.